SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-19-020729
Filing Date
2019-10-28
Accepted
2019-10-28 15:43:44
Documents
2
Period of Report
2019-10-28
Effectiveness Date
2019-10-28

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A inbp20191021_def14a.htm DEF 14A 495618
2 ibp_logo.jpg GRAPHIC 12671
  Complete submission text file 0001437749-19-020729.txt   513986
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31668 | Film No.: 191172983
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences